PORTFOLIO
ABL has manufactured a broad range of viral vectors
using a diversity of cell lines
We are pioneers in the manufacturing of viral vectors. We have been producing MVA, Vaccina and Pox virus since the early 90s. Today, we offer a broad range of viral vectors using a diversity of cell lines such as CEF, HeLa, HEK293, A549, VERO cells.
Thanks to our > 25 years expertise, we are the right candidate to support your Vaccinia and MVA projects with a successful track record in delivering GMP clinical batches up to phase 3 through adherent and suspension cell culture.
